Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ursodeoxycholic acid 300 mg syrup
Therapeutic Category
Urology, Gastroenterology, Hepatology
Dosage Form
Syrup
Packaging Type
Bottle
Packaging
100 ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ursodeoxycholic Acid 300 mg Syrup is a bile acid used to dissolve cholesterol-rich gallstones and to treat certain liver and gallbladder conditions. It works by reducing the cholesterol content in bile and gradually dissolving stones. Additionally, it protects liver cells, improves bile flow, and slows disease progression in conditions like primary biliary cirrhosis and cholestatic liver diseases.
Ursodeoxycholic Acid syrup is usually well tolerated. Mild side effects may include diarrhea, nausea, or abdominal discomfort. Rarely, allergic reactions or changes in liver function tests may occur. Any persistent or serious effects should be reported to a physician immediately.
This syrup is indicated for the treatment of small gallstones in patients who do not wish to undergo surgery, primary biliary cholangitis (PBC), and other chronic cholestatic liver diseases. It may also be prescribed in pediatric and adult patients for improving bile flow in certain metabolic and hepatobiliary disorders.
Use this medication under strict medical supervision. It is not suitable for patients with calcified gallstones or complete biliary obstruction. Pregnant or breastfeeding women should consult a doctor before use. Regular monitoring of liver function is advised during long-term treatment.
Store below 25°C in a dry place, away from direct light and heat. Keep the bottle tightly closed and out of the reach of children. Shake well before each use.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ursodeoxycholic acid Syrup has strong demand in the hepatology and gastroenterology segment, making it a valuable prescription product for pharma distributors, wholesalers, and franchise partners. It is widely used for cholestatic liver diseases, fatty liver support, pediatric liver disorders, and bile flow improvement, ensuring steady long-term prescription demand.
Medical distributors and agencies benefit from the increasing prevalence of liver disorders and digestive health issues. Helps improve bile flow and liver function support Used in cholestatic liver diseases and fatty liver management support Suitable for pediatric and adult liver care (depending on prescription use) Widely prescribed by gastroenterologists and hepatologists Important in long-term liver health management Strong demand in hospital and specialty clinic prescriptions This makes it a steady-moving gastro-hepatology care product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ursodeoxycholic Acid 300 mg Syrup with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent gastroenterology prescription demand, long-term chronic liver care usage, repeat therapy cycles, and stable year-round turnover in the hepatology segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete liver and gastro care product portfolio access to build a strong presence in the hepatology and digestive health market.